Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BAX (BCL2 Associated X, Apoptosis Regulator) is a key pro-apoptotic member of the Bcl-2 gene family. It promotes programmed cell death by permeabilizing the mitochondrial outer membrane, leading to cytochrome c release and caspase activation. Its expression and activation are tightly regulated, and dysregulation of BAX function is implicated in cancer and other diseases. While BAX itself is not typically directly targeted by drugs, it is an important component of the apoptotic pathway and strategies exist to restore or enhance its pro-apoptotic function, particularly in cancer cells.
BAX itself is not directly targeted by drugs, but its activity can be modulated through targeting upstream regulators or downstream effectors in the apoptotic pathway. Some experimental drugs aim to restore BAX function in cancer cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BCL2 Associated X, Apoptosis Regulator (BAX).